Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

COVID-19: Daily Top 10 Papers

  Malignant Lymphoma

  Free Subscription

Articles published in Lab Invest

Retrieve available abstracts of 13 articles:
HTML format

Single Articles

    March 2021
  1. FREICHE V, Cordonnier N, Paulin MV, Huet H, et al
    Feline low-grade intestinal T cell lymphoma: a unique natural model of human indolent T cell lymphoproliferative disorder of the gastrointestinal tract.
    Lab Invest. 2021 Mar 10. pii: 10.1038/s41374-021-00581.
    PubMed     Abstract available

    October 2020
  2. TAGUCHI T, Kurata M, Onishi I, Kinowako Y, et al
    SECISBP2 is a novel prognostic predictor that regulates selenoproteins in diffuse large B-cell lymphoma.
    Lab Invest. 2020 Oct 19. pii: 10.1038/s41374-020-00495.
    PubMed     Abstract available

    May 2020
  3. MIYOSHI H, Sato K, Kabeya Y, Yonezawa S, et al
    Deep learning shows the capability of high-level computer-aided diagnosis in malignant lymphoma.
    Lab Invest. 2020 May 29. pii: 10.1038/s41374-020-0442.
    PubMed     Abstract available

    September 2019
  4. YAMAMOTO K, Abe S, Honda A, Hashimoto J, et al
    Fatty acid beta oxidation enzyme HADHA is a novel potential therapeutic target in malignant lymphoma.
    Lab Invest. 2019 Sep 16. pii: 10.1038/s41374-019-0318.
    PubMed     Abstract available

    June 2019
  5. WANG WG, Jiang XN, Sheng D, Sun CB, et al
    PD-L1 over-expression is driven by B-cell receptor signaling in diffuse large B-cell lymphoma.
    Lab Invest. 2019 Jun 13. pii: 10.1038/s41374-019-0262.
    PubMed     Abstract available

    January 2019
  6. NAGATO T, Ueda S, Takahara M, Kishibe K, et al
    Cyclin-dependent kinase 1 and survivin as potential therapeutic targets against nasal natural killer/T-cell lymphoma.
    Lab Invest. 2019 Jan 21. pii: 10.1038/s41374-018-0182.
    PubMed     Abstract available

    November 2018
  7. EL JAMAL SM, Grada Z, El Dinali MH, Zhou H, et al
    MEF2B is a member of the BCL6 gene transcriptional complex and induces its expression in diffuse large B-cell lymphoma of the germinal center B-cell-like type.
    Lab Invest. 2018 Nov 16. pii: 10.1038/s41374-018-0152.
    PubMed     Abstract available

    August 2018
  8. JUSKEVICIUS D, Jucker D, Dietsche T, Perrina V, et al
    Novel cell enrichment technique for robust genetic analysis of archival classical Hodgkin lymphoma tissues.
    Lab Invest. 2018 Aug 7. pii: 10.1038/s41374-018-0096.
    PubMed     Abstract available

    February 2018
  9. KINOWAKI Y, Kurata M, Ishibashi S, Ikeda M, et al
    Glutathione peroxidase 4 overexpression inhibits ROS-induced cell death in diffuse large B-cell lymphoma.
    Lab Invest. 2018 Feb 20. pii: 10.1038/s41374-017-0008.
    PubMed     Abstract available

    August 2017
  10. JIANG N, Chen C, Gong Q, Shields K, et al
    Flow cytometric sorting coupled with exon capture sequencing identifies somatic mutations in archival lymphoma tissues.
    Lab Invest. 2017 Aug 7. doi: 10.1038/labinvest.2017.
    PubMed     Abstract available

    July 2017
  11. KNECHT H, Johnson NA, Haliotis T, Lichtensztejn D, et al
    Disruption of direct 3D telomere-TRF2 interaction through two molecularly disparate mechanisms is a hallmark of primary Hodgkin and Reed-Sternberg cells.
    Lab Invest. 2017;97:772-781.
    PubMed     Abstract available

    June 2017
  12. SCHMIDT J, Bonzheim I, Steinhilber J, Montes-Mojarro IA, et al
    EMMPRIN (CD147) is induced by C/EBPbeta and is differentially expressed in ALK+ and ALK- anaplastic large-cell lymphoma.
    Lab Invest. 2017 Jun 5. doi: 10.1038/labinvest.2017.
    PubMed     Abstract available

    April 2017
  13. HWANG SR, Murga-Zamalloa C, Brown N, Basappa J, et al
    Pyrimidine tract-binding protein 1 mediates pyruvate kinase M2-dependent phosphorylation of signal transducer and activator of transcription 3 and oncogenesis in anaplastic large cell lymphoma.
    Lab Invest. 2017 Apr 17. doi: 10.1038/labinvest.2017.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Malignant Lymphoma is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.